Maxell, Ltd. v. Amperex Technology Limited

Procedural entryThis page is a short order in Maxell, Ltd. v. Amperex Technology Limited. Read the opinion of the Court — 94 F.4th 1369
Court of Appeals for the Federal Circuit·Decided January 23, 2025·No. 23-2256·Unpublished

Opinion

Case: 23-2256 Document: 39 Page: 1 Filed: 01/23/2025

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

MAXELL, LTD., Appellant

v.

AMPEREX TECHNOLOGY LIMITED, Appellee ______________________

2023-2256, 2023-2258 ______________________

Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2021- 01440, IPR2021-01443.

-------------------------------------------------

2023-2257 ______________________ Case: 23-2256 Document: 39 Page: 2 Filed: 01/23/2025

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2021- 01441. ______________________

Decided: January 23, 2025 ______________________

ERIK SHALLMAN, Vinson & Elkins LLP, Austin, TX, ar- gued for appellant. Also represented by CORBIN CESSNA, JEFFREY TA-HWA HAN, HILARY L. PRESTON; ERIC JOSEPH KLEIN, PAIGE HOLLAND WRIGHT, Dallas, TX.

BRADY COX, Alston & Bird LLP, Dallas, TX, argued for appellee. Also represented by KIRK T. BRADLEY, CHRISTOPHER TIMOTHY LAWN DOUGLAS, NICHOLAS CHRISTOPHER MARAIS, Charlotte, NC. ______________________

Before LOURIE, REYNA, and CHEN, Circuit Judges. LOURIE, Circuit Judge. Maxell, Ltd. appeals from three decisions of the U.S. Patent Trial and Appeal Board (“the Board”) holding claims 1–5 of U.S. Patent 8,691,446 (“the ’446 patent”), claims 1–5 of U.S. Patent 9,350,019 (“the ’019 patent”), and claims 1–11 of U.S. Patent 9,077,035 (“the ’035 patent”) un- patentable as obvious. 1 Amperex Tech. Ltd. v. Maxell, Ltd., No. IPR2021-01440 (P.T.A.B. Mar. 28, 2023) (“’1440 Deci- sion”), Appeal No. 23-2256, J.A. 1–42; Amperex Tech. Ltd.

1 Appeal No. 23-2256 (relating to the ’446 patent) and Appeal No. 23-2258 (relating to the ’019 patent) were consolidated for briefing. Appeal No. 23-2257 (relating to the ’035 patent) was briefed separately. Because the issues across the appeals largely overlap, we address all three to- gether. Case: 23-2256 Document: 39 Page: 3 Filed: 01/23/2025

MAXELL, LTD. v. AMPEREX TECHNOLOGY LIMITED 3

v. Maxell, Ltd., No. IPR2021-01443 (P.T.A.B. Mar. 28, 2023), Appeal No. 23-2256, J.A. 43–85; Amperex Tech. Ltd. v. Maxell, Ltd., No. IPR2021-01441 (P.T.A.B. Mar. 28, 2023) (“’1441 Decision”), Appeal No. 23-2257, J.A. 1–44. 2 For the following reasons, we affirm. BACKGROUND Maxell owns the ’446 patent, the ’019 patent, and the ’035 patent, which are each generally directed to recharge- able lithium-ion batteries. The patents seek to address problems associated with basic lithium cobalt oxide (LiCoO2) electrode materials, such as structural decay, re- liability, and gas generation, by incorporating cathode ma- terials that contain at least two lithium-containing transition metal oxides having different average particle sizes. See, e.g., ’446 patent, Abstract. For example, claim 1 of the ’446 patent recites: 1. A nonaqueous secondary battery comprising: a positive electrode having a positive electrode mix- ture layer, a negative electrode, and a nonaqueous electrolyte, wherein the positive electrode contains, as an active material, at least two lithium- containing transition metal oxides having different average particle sizes, wherein said at least two lithium-contain- ing transition metal oxides having differ- ent average particle sizes have different compositions of elements between them,

2 For simplicity, we cite the ’1440 Decision on issues pertaining to both the ’446 and ’019 patents and the ’1441 Decision on issues pertaining to the ’035 patent. Case: 23-2256 Document: 39 Page: 4 Filed: 01/23/2025

said lithium-containing transition metal oxide having the smallest average particle size is a lithium-containing transition metal oxide represented by the formula (1): LixM1yM2zM3vO2 (1) wherein M1 represents at least one transi- tion metal element selected from Co, Ni and Mn, M2 represents Mg and at least one metal element selected from the group con- sisting of Ti, Zr, Ge, Nb, Al and Sn, M3 rep- resents an element other than Li, M1 and M2, and x, y, z and v are numbers satisfying the equations respectively: 0.97≤x<1.02, 0.8≤y<1.02, 0.002≤z≤0.05, and 0≤v≤0.05, the positive electrode mixture layer has a density of at least 3.5 g/cm3, and the nonaqueous electrolyte contains a com- pound having at least two nitrile groups in the molecule. Id. col. 28 ll. 35–60. All three patents recite the limitation that the “lith- ium-containing transition metal oxide having the smallest average particle size is a lithium-containing transition metal oxide represented by the formula (1): LixM yM zM vO2.” See, e.g., id. col. 28 ll. 44–48. Relevant 1 2 3

to these appeals is the identity of M2 in that formula. Each of the ’446 and ’035 patents claims that M2 “represents Mg and at least one metal element selected from the group con- sisting of Ti, Zr, Ge, Nb, Al and Sn.” Id. col. 28 ll. 50–52; ’035 patent, col. 29 ll. 33–35. Similarly, the ’019 patent claims that M2 “represents Mg, or Mg and at least one metal element selected from the group consisting of Ti, Zr, Ge, Nb, Al and Sn.” ’019 patent, col. 28 ll. 54–56. Accord- ingly, all three patents recite that M2 can be represented by Mg and Al. Case: 23-2256 Document: 39 Page: 5 Filed: 01/23/2025

MAXELL, LTD. v. AMPEREX TECHNOLOGY LIMITED 5

In addition to the cathode material, the patents seek to enhance thermal stability of the battery through the use of additives in the nonaqueous electrolyte. Each of the ’446 and ’019 patents claims that the electrolyte “contains a compound having at least two nitrile groups in the mole- cule.” ’446 patent, col. 28 ll. 59–60; ’019 patent, col. 28 ll. 65–67. The ’035 patent claims that the electrolyte “con- tains a fluorine-containing organic solvent.” ’035 patent, col. 29 ll. 53–54. Amperex Technology Limited (“Amperex”) petitioned for, and the Board instituted, inter partes review (“IPR”) of all claims of the ’446, ’035, and ’019 patents. Amperex ar- gued, inter alia, that claims 1–5 of the ’446 patent and claims 1–5 of the ’019 patent are invalid because, at the time of the invention, they would have been obvious over U.S. Patent Application Publication 2006/0257745 (“Choi”) 3 in combination with U.S. Patent Application 2005/0208371 (“Kim”), and that claims 1–11 of the ’035 pa- tent are invalid because, at the time of the invention, they would have been obvious over Choi in combination with U.S. Patent Application 2004/0197667 (“Noh”). Choi, which relates to “lithium batteries having high voltage stability, thermal stability and high rate discharge characteristics,” discloses a cathode material for a lithium battery that includes large and small diameter materials. Choi, Abstract, ¶ 2. The small diameter material can have the formula LixCo1-y-zNiyMzO2-αXα, where M “is selected from the group consisting of Al, Ni, Mn, Cr, Fe, Mg, Sr, V, rare earth elements and mixtures thereof.” Choi, ¶¶ 31–32. Choi further discloses that the battery includes

3 In each of the ’446 and ’019 patent IPR, Amperex cited Chinese Patent Application Publication 1822414, the Chinese counterpart to Choi. For simplicity, we cite to the U.S. publication of Choi. Case: 23-2256 Document: 39 Page: 6 Filed: 01/23/2025

an electrolytic solution that can comprise benzonitrile and acetonitrile, i.e., mononitrile solvents. Id. ¶ 61. Kim relates to improving thermal stability of cathode materials, such as lithium-containing transition metal ox- ide, through “a protection layer formed by a complex be- tween the surface of a cathode active material and an aliphatic nitrile compound.” Kim, Abstract, ¶ 8. The ali- phatic nitrile compound can be succinonitrile, i.e., a dini- trile compound. Id. ¶ 32.

Free access — add to your briefcase to read the full text and ask questions with AI

Maxell, Ltd. v. Amperex Technology Limited, (Fed. Cir. 2025).

Maxell, Ltd. v. Amperex Technology Limited (Maxell, Ltd. v. Amperex Technology Limited) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re Lance G. Peterson and Ioannis Vasatis
315 F.3d 1325 (Federal Circuit, 2003)
Genentech, Inc. v. Hospira, Inc.
946 F.3d 1333 (Federal Circuit, 2020)